Company news
Senhwa Biosciences Inc news in 2023
Senhwa Biosciences Inc's news releases, calls and decks from 2023, newest first.
Senhwa Biosciences Received US FDA IND Approval for Phase II Study of Silmitasertib in Patients with Community-Acquired Pneumonia Associated with Viral Infection
November 22, 2023
Senhwa Biosciences Announces First Patient Successfully Dosed in Taiwan Phase II Study of Silmitasertib in Hospitalized Adults with COVID-19
November 10, 2023